DPWRX
Price
$75.60
Change
+$0.34 (+0.45%)
Updated
Dec 3 closing price
Net Assets
1.04B
RNPCX
Price
$71.95
Change
+$0.37 (+0.52%)
Updated
Dec 3 closing price
Net Assets
162.64B
Interact to see
Advertisement

DPWRX vs RNPCX

Header iconDPWRX vs RNPCX Comparison
Open Charts DPWRX vs RNPCXBanner chart's image
BNY Mellon Worldwide Growth I
Price$75.60
Change+$0.34 (+0.45%)
VolumeN/A
Net Assets1.04B
American Funds New Perspective R3
Price$71.95
Change+$0.37 (+0.52%)
VolumeN/A
Net Assets162.64B
DPWRX vs RNPCX Comparison Chart in %
View a ticker or compare two or three
VS
DPWRX vs. RNPCX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DPWRX is a Buy and RNPCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 163B vs. DPWRX (1.04B). DPWRX pays higher dividends than RNPCX: DPWRX (0.26) vs RNPCX (0.21). DPWRX was incepted earlier than RNPCX: DPWRX (30 years) vs RNPCX (24 years). RNPCX (1.06) is less costly to investors than DPWRX (0.91). RNPCX is a more actively managed with annual turnover of: 24.00 vs. DPWRX (13.83). RNPCX has a lower initial minimum investment than DPWRX: RNPCX (250) vs DPWRX (1000). RNPCX annual gain was more profitable for investors over the last year : 11.50 vs. DPWRX (0.04). RNPCX return over 5 years is better than : 22.60 vs. DPWRX (16.76).
DPWRXRNPCXDPWRX / RNPCX
Total Expense Ratio0.911.0686%
Annual Report Gross Expense Ratio0.911.0686%
Fund Existence30 years24 years-
Gain YTD14.00519.77771%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.04B163B1%
Annual Yield % from dividends0.260.21122%
Returns for 1 year0.0411.500%
Returns for 3 years19.5943.9745%
Returns for 5 years16.7622.6074%
Returns for 10 years46.2390.0351%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATNM1.450.07
+5.07%
Actinium Pharmaceuticals
AXSM147.815.72
+4.03%
Axsome Therapeutics
ARLO14.270.38
+2.74%
Arlo Technologies
TLSI6.43-0.02
-0.31%
TriSalus Life Sciences
MNSBP24.85-0.12
-0.50%
MainStreet Bancshares